Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugs.

Garnier P, Wang XT, Robinson MA, van Kasteren S, Perkins AC, Frier M, Fairbanks AJ, Davis BG.

J Drug Target. 2010 Dec;18(10):794-802. doi: 10.3109/1061186X.2010.529909.

PMID:
21047273
[PubMed - indexed for MEDLINE]
2.

Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.

Perkins AC, Frier M, Blackshaw PE, Spiller RC, Fairbairn KJ, Dansereau RJ, Kinghorn T, San P, Hosking D.

Int J Pharm. 2006 Mar 27;311(1-2):20-5. Epub 2006 Jan 20.

PMID:
16431045
[PubMed - indexed for MEDLINE]
3.
4.

Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging.

Hunt AP, Frier M, Johnson RA, Berezenko S, Perkins AC.

Eur J Pharm Biopharm. 2006 Jan;62(1):26-31. Epub 2005 Sep 8.

PMID:
16154332
[PubMed - indexed for MEDLINE]
5.

LEAPT: lectin-directed enzyme-activated prodrug therapy.

Robinson MA, Charlton ST, Garnier P, Wang XT, Davis SS, Perkins AC, Frier M, Duncan R, Savage TJ, Wyatt DA, Watson SA, Davis BG.

Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14527-32. Epub 2004 Sep 24.

PMID:
15448212
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Radionuclide imaging in drug development.

Perkins AC, Frier M.

Curr Pharm Des. 2004;10(24):2907-21. Review.

PMID:
15379658
[PubMed - indexed for MEDLINE]
7.

Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECD.

Terán M, Savio E, Paolino A, Frier M.

Eur J Pharm Biopharm. 2004 Mar;57(2):347-52.

PMID:
15018995
[PubMed - indexed for MEDLINE]
8.

Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancer.

Frier M.

Mini Rev Med Chem. 2004 Jan;4(1):61-8. Review.

PMID:
14754444
[PubMed - indexed for MEDLINE]
9.

Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tract.

Stevens HN, Wilson CG, Welling PG, Bakhshaee M, Binns JS, Perkins AC, Frier M, Blackshaw EP, Frame MW, Nichols DJ, Humphrey MJ, Wicks SR.

Int J Pharm. 2002 Apr 2;236(1-2):27-34.

PMID:
11891067
[PubMed - indexed for MEDLINE]
10.

The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water.

Perkins AC, Wilson CG, Frier M, Blackshaw PE, Dansereau RJ, Vincent RM, Wenderoth D, Hathaway S, Li Z, Spiller RC.

Int J Pharm. 2001 Jul 17;222(2):295-303.

PMID:
11427359
[PubMed - indexed for MEDLINE]
11.

The effect of the nasal cycle on mucociliary clearance.

Soane RJ, Carney AS, Jones NS, Frier M, Perkins AC, Davis SS, Illum L.

Clin Otolaryngol Allied Sci. 2001 Feb;26(1):9-15.

PMID:
11298159
[PubMed - indexed for MEDLINE]
12.

Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects.

Perkins AC, Wilson CG, Frier M, Blackshaw PE, Juan D, Dansereau RJ, Hathaway S, Li Z, Long P, Spiller RC.

Aliment Pharmacol Ther. 2001 Jan;15(1):115-21.

PMID:
11136284
[PubMed - indexed for MEDLINE]
Free Article
13.

Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595.

Hughes OD, Perkins AC, Frier M, Wastie ML, Denton G, Price MR, Denley H, Bishop MC.

BJU Int. 2001 Jan;87(1):39-46.

PMID:
11121991
[PubMed - indexed for MEDLINE]
14.

Nuclear medicine imaging and drug delivery.

Perkins A, Frier M.

Nucl Med Commun. 2000 May;21(5):415-6. No abstract available.

PMID:
10874696
[PubMed - indexed for MEDLINE]
15.

Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations.

Hebden JM, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC, Wilson CG, Spiller RC.

Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1379-85.

PMID:
10654798
[PubMed - indexed for MEDLINE]
16.

Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.

Hughes OD, Bishop MC, Perkins AC, Wastie ML, Denton G, Price MR, Frier M, Denley H, Rutherford R, Schubiger PA.

J Clin Oncol. 2000 Jan;18(2):363-70.

PMID:
10637251
[PubMed - indexed for MEDLINE]
Free Article
17.

Dry powder dosing in liquid vehicles: ocular tolerance and scintigraphic evaluation of a perfluorocarbon suspension.

Zhu Y, Wilson CG, Meadows D, Olejnik O, Frier M, Washington N, Musson R.

Int J Pharm. 1999 Nov 30;191(2):79-85.

PMID:
10564834
[PubMed - indexed for MEDLINE]
18.

Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations.

Perkins AC, Wilson CG, Frier M, Vincent RM, Blackshaw PE, Dansereau RJ, Juhlin KD, Bekker PJ, Spiller RC.

Int J Pharm. 1999 Sep 20;186(2):169-75.

PMID:
10486435
[PubMed - indexed for MEDLINE]
19.

Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Hebden JM, Wilson CG, Spiller RC, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC.

Pharm Res. 1999 Jul;16(7):1087-92.

PMID:
10450935
[PubMed - indexed for MEDLINE]
20.

An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma.

Davies Q, Perkins AC, Roos JC, Molthoff CF, Verheijen RH, Frier M, Kenemans P, Broadhead T, Sopwith M, Symonds EM.

Br J Obstet Gynaecol. 1999 Jan;106(1):31-7.

PMID:
10426256
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk